Aegis Therapeutics has received US patent covering pharmaceutical composition of octreotide. The octreotide formulations incorporate Aegis' Intravail/ProTek excipients suitable for all routes of administration including oral, buccal, ...
Tags: Octreotide Formulations, Aegis Therapeutics, polysorbate surfactants